CV Therapeutics, Inc. (NASDAQ:CVTX.DL)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.
A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.